[1]
Vallipi Vamsi Krishna et al. 2026. Development and In Vitro Evaluation of Rizatriptan Benzoate Oral Disintegrating Tablets Using Superdisintegrants for Enhanced Patient Compliance. International Journal of Pharmaceutical Drug Design. 3, 2 (Jul. 2026), 35–44. DOI:https://doi.org/10.62896/ijpdd.v3.i2.04.